We are international
Donate
TEXT SIZE   


Dr. Niesvizky - Phase 3b UPFRONT Study: Safety and Efficacy of Weekly Bortezomib Maintenance Therapy After Bortezomib-Based Induction Regimens In Elderly, Newly Diagnosed Multiple Myeloma Patients
Ruben Niesvizky, MD
Weill Cornell Medical College
New York, New York
USA
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles